Home / News / India News / Article /
Delhi HC seeks Centre's stand on PIL against Covaxin trial on 2-18 age group
Updated On: 19 May, 2021 12:02 PM IST | New Delhi | PTI
Covaxin manufacturer Bharat Biotech received the DCGI approval to conduct clinical trials of Covaxin in children on May 11, following the Central Drugs Standard Control Organisation`s subject expert committee`s recommendation, under certain conditions.
Listen to this article :
This picture has been used for representational purpose
Clinical trials to test Covaxin vaccine`s efficacy in children between two to 18 years of age will begin in 10-12 days, top officials said on Tuesday.
Addressing the Union Health Ministry press conference, NITI Aayog`s Member Health, Dr V.K. Paul said: "Covaxin has been approved by the Drugs Controller General of India (DCGI) for Phase 2 and 2 clinical trials in the age group of two to 18 years. I have been told that trials will begin in the next 10-12 days."
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT